The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks, according to a proprietary formula designed to identify those stocks that combine two important characteristics — strong fundamentals and a valuation that looks inexpen
The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks, according to a proprietary formula designed to identify those stocks that combine two important characteristics — strong fundamentals and a valuation that looks inexpen
The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks, according to a proprietary formula designed to identify those stocks that combine two important characteristics — strong fundamentals and a valuation that looks inexpen
The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks, according to a proprietary formula designed to identify those stocks that combine two important characteristics — strong fundamentals and a valuation that looks inexpen
What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is down -0.78%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.50%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.85%. Stocks this morning are moderately lower on the risks...
The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks, according to a proprietary formula designed to identify those stocks that combine two important characteristics — strong fundamentals and a valuation that looks inexpen
The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks, according to a proprietary formula designed to identify those stocks that combine two important characteristics — strong fundamentals and a valuation that looks inexpen
The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks, according to a proprietary formula designed to identify those stocks that combine two important characteristics — strong fundamentals and a valuation that looks inexpen
In trading on Wednesday, shares of SiteOne Landscape Supply Inc (Symbol: SITE) crossed below their 200 day moving average of $150.92, changing hands as low as $146.16 per share. SiteOne Landscape Supply Inc shares are currently trading down about 6% on the day. The chart belo
In trading on Wednesday, shares of Evertec, Inc. (Symbol: EVTC) crossed below their 200 day moving average of $36.31, changing hands as low as $36.16 per share. Evertec, Inc. shares are currently trading off about 1.1% on the day. The chart below shows the one year performanc
Gen Z Americans -- alongside millennials, both digitally native generations -- seem to be influencing the real estate market. See: Grant Cardone Reveals 6 Cities He Would Buy Investment Property in...
(RTTNews) - Roche (RHHBY) said the Elecsys IL-6 immunoassay has become the first IL-6 test to have a certified claim for use in diagnosis of neonatal sepsis, in countries accepting the CE Mark. The company noted that testing IL-6 can indicate a neonatal sepsis infection earlier t
(RTTNews) - Genentech, Inc., affiliated to Swiss drug major Roche Holding AG (RHHBY), announced Wednesday results from the primary analysis of the Phase III ALINA study of Alecensa (alectinib) in people with anaplastic lymphoma kinase or ALK-positive non-small cell lung cancer or
Swedish bank Handelsbanken reported a bigger than expected rise in third-quarter profit on Wednesday as soaring interest rates lifted income while credit losses remained marginal and far below forecast.
(RTTNews) - Swiss engineering company ABB Ltd.(ANN.L, ABB) reported Wednesday that its third-quarter net income attributable to the company climbed 145 percent $882 million from last year's $360 million.
Prices of most base metals gained on Wednesday as better-than-expected economic data from China brightened the demand outlook of the world's top consumer.
The U.S. health regulator has approved Hyloris Pharmaceuticals' drug for post-operative pain, the Belgium-based company said on Wednesday, adding that it expects to launch the non-opioid treatment in the United States by early next year.
With text messages and emails under tightened surveillance, financial firms may now have to screen staff video calls for possible rule-breaking, amid concern regulators are poised to scrutinise such calls for compliance breaches.
A hard-won deal on the European Union's negotiating stance for this year's U.N. climate talks has revealed regional rifts that anticipate global tensions at the COP28 summit.